Bayer recently announced the 2016 recipients of the Bayer Hemophilia Awards Program (BHAP), which is dedicated to supporting innovative research and educational initiatives to benefit individuals with hemophilia worldwide. This year, the company awarded nearly $2 million in funding to 16 recipients in 11 countries. Since its inception in 2002, BHAP has awarded $31 million to 255 grant recipients in 32 countries.
The six recipients from the US are Moanaro Biswas, PhD, of University of Florida Cancer & Genetics Research Center; James Dahlman, PhD, of Georgia Institute of Technology; Gary Gilbert, MD, of Boston VA Research Institute; Rahul Khanna, PhD, of University of Mississippi; Michael Milone, MD, of University of Pennsylvania; and Maurizio Tomaiuolo, PhD, of University of Pennsylvania.
“For more than 20 years, Bayer has been committed to working with the hemophilia community, and the Bayer Hemophilia Awards Program grants have played a significant role in driving the next generation of insights for patients and their families,” said Dario Mirski, MD, senior vice president and head of medical affairs for the Americas at Bayer, in a press release. “It is with great pride that we continue to support research and clinical efforts that have the potential to make an impact on the diagnosis and treatment of bleeding disorders.”
Source: Healio.com, August 24, 2016
